Vitro Biopharma’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Vitro Biopharma manufactures and markets specialty biological products for pituitary hormone and tumor marker diagnostic testing. Read more

12 Followers on Owler
12 Followers on Owler
12 Followers on Owler
12 Followers on Owler

Vitro Biopharma manufactures and markets specialty biological products for pituitary hormone and tumor marker diagnostic testing. Read more

Jim Musick's photo - President & CEO of Vitro Biopharma

President & CEO

Jim Musick

CEO Approval Rating

75/100

Founded:

1986

Status:

PublicIndependent CompanyOtherVODG

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Vericel is the top competitor of Vitro Biopharma. Vericel was founded in 1989, and its headquarters is in Cambridge, Massachusetts. Like Vitro Biopharma, Vericel also operates in the Pharmaceuticals field. Vericel has 237 more employees than Vitro Biopharma.

Athersys is seen as one of Vitro Biopharma's top competitors. Athersys was founded in Cleveland, Ohio} in 1995. Like Vitro Biopharma, Athersys also works within the Pharmaceuticals field. Compared to Vitro Biopharma, Athersys generates $5.5M more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of Vitro Biopharma?

Quarterly and Annual Revenue

Coming soon for Vitro Biopharma!

Annual Revenue

$ < 1M

Vitro Biopharma's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 39.5M.

Acquisitions

No recent acquisitions found related to Vitro Biopharma

Vitro Biopharma Funding History

$1M

Since Vitro Biopharma was founded in 1986, it has participated in 1 round of funding. In total Vitro Biopharma has raised $1.0M. Vitro Biopharma's funding round was on Jan 2020 for a total of $1.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Jan 2020
$1M
-

Since Vitro Biopharma was founded in 1986, it has participated in 1 round of funding. In total Vitro Biopharma has raised $1.0M. Vitro Biopharma's funding round was on Jan 2020 for a total of $1.0M

Investments

No recent investments found related to Vitro Biopharma

Vitro Biopharma News

June 29, 2020FinanzNachrichten

Vitro Bio-Pharma 2nd Quarter Ended April 30th 2020 Financial Results of Operations and Shareholder Letter

GOLDEN, COLO / ACCESSWIRE / June 29, 2020 / Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma... See more »
June 3, 2020FinanzNachrichten

Vitro Biopharma Signs MOU with GIOSTAR for COVID-19 IND Using AlloRx Stem Cells

GOLDEN, CO / ACCESSWIRE / June 2, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro entered i... See more »
May 7, 2020FinanzNachrichten

Vitro Diagnostic Inc. dba Vitro Biopharma Featured in New Research Report

GOLDEN, CO / ACCESSWIRE / May 7, 2020 / Vitro Diagnostic Inc. dba Vitro Biopharma (OTC PINK:VODG), an... See more »
March 25, 2020FinanzNachrichten

Vitro Biopharma First Quarter ended January 31, 2020 Financial Results of Operations

GOLDEN, CO / ACCESSWIRE / March 26, 2020 / Vitro Diagnostics, Inc. (OTCPINK:VODG), dba Vitro Biopharm... See more »
March 18, 2020FinanzNachrichten

Stem Cell Therapy for the Coronavirus COVID-19 Pandemic

GOLDEN, CO / ACCESSWIRE / March 18, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro Biophar... See more »
February 27, 2020FinanzNachrichten

Stem Cell Therapy for Coronavirus Infection

GOLDEN, CO / ACCESSWIRE / February 27, 2020 /Vitro Diagnostics, Inc. (OTCPK:VODG), dba Vitro Biopharm... See more »

Vitro Biopharma Blogs

April 21, 2020Vitro Biopharma Blog

Vitro Biopharma Submits IND Application to FDA for AlloRx Stem Cell(R) Therapy of COVID-19

GOLDEN, CO / ACCESSWIRE / April 21, 2020 / Vitro Diagnostics, Inc. (OTCPINK:VODG), dba Vitro Biopharm... See more »
April 8, 2020Vitro Biopharma Blog

Vitro Biopharma Receives Recognition from BioInformant

Coronavirus disease (COVID-19) is an emerging global pandemic that is threatening the viability of he... See more »
March 17, 2020Vitro Biopharma Blog

Stem Cell Therapy for the Coronavirus COVID-19 Pandemic

Golden, Colorado—March 17, 2020—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma reports on... See more »
March 9, 2020Vitro Biopharma Blog

Anti-Aging Effects of AlloRx Stem Cell Therapy & STEMulize

As we age, our cells get sick and die. When a cell dies, it creates a cascade of events, leading to i... See more »
January 23, 2020Vitro Biopharma Blog

Vitro Biopharma 2019 CEO Shareholder Letter: Record Revenues Leading to Further Growth into 2020

Golden, Colorado—January 23, 2020—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announc... See more »
January 22, 2020Vitro Biopharma Blog

Leading Denver-Based Orthopedic Surgeon to Join Vitro Biopharma’s Scientific Advisory Board

GOLDEN, CO / ACCESSWIRE / November 5, 2019 / Vitro Diagnostics, Inc. (OTCPK:VODG), dba Vitro Biopharm... See more »
October 2, 2019Vitro Biopharma Blog

Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations

The post Vitro Biopharma 3rd Quarter ended July 31st 2019 Financial Results of Operations appeared fi... See more »

Vitro Biopharma Press Releases

January 25, 2019CENTRALCHARTS

Record Revenues from Stem Cell Treatments

GOLDEN, CO / ACCESSWIRE / January 24, 2019 / VitroDiagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharm... See more »
December 11, 2018CENTRALCHARTS

Vitro Biopharma Receives ISO 9001 Certification

GOLDEN, CO / ACCESSWIRE / December 11, 2018 / VitroDiagnostics, Inc. (OTCPK: VODG), dba Vitro Biophar... See more »
December 11, 2018StreetInsider

Vitro Biopharma Receives ISO 9001 Certification

VitroDiagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma (''Vitro'') one of theworld's emerging biot... See more »
May 3, 2018MarketersMedia

Vitro Bio-Pharma Debt Re-Capitalization and Executive Team Formation

GOLDEN, CO / ACCESSWIRE / May 3, 2018 / Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro BioPharma, a... See more »
November 8, 2016Free Press Release 2

VetStem Biopharma Acquires 24 New Adipose Stem Cell Patents

VetStem Biopharma has completed the purchase of 24 issued patents in the area of adipose stem cell th... See more »
February 29, 2016Accesswire

Increased Revenue and Expansion Activities to Fuel Growth

GOLDEN, CO / ACCESSWIRE / March 1, 2016 / Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma,... See more »
December 29, 2015Accesswire

Vitro Biopharma Advances Stem Cell Activation Therapy for Concussion

GOLDEN, CO / ACCESSWIRE / December 29, 2015 / Vitro Diagnostics, Inc. (OTC: VODG), dba Vitro Biopharm... See more »

Social Media

Headquarters

4621 Technology Drive Golden

Golden, Colorado80403

303-999-2130

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Vitro Biopharma manufactures and markets specialty biological products for pituitary hormone and tumor marker diagnostic testing. Vitro Biopharma was founded in 1986. Vitro Biopharma's headquarters is located in Golden, Colorado, USA 80403. It has rai...

CEO

Vitro Biopharma's President & CEO, Jim Musick, currently has an approval rating of 75%. Vitro Biopharma's primary competitors are Vericel, Athersys &

Website

vitrobiopharma.com

Frequently Asked Questions about Vitro Biopharma

  1. When was Vitro Biopharma founded?

    Vitro Biopharma was founded in 1986
  2. Who is Vitro Biopharma's CEO?

    Vitro Biopharma's CEO is Jim Musick
  3. How much revenue does Vitro Biopharma generate?

    Vitro Biopharma generates $ < 1M in revenue
  4. How much funding does Vitro Biopharma have?

    Vitro Biopharma has historically raised $1M in funding
  1. Where is Vitro Biopharma's headquarters?

    Vitro Biopharma's headquarters is in Golden Colorado, USA
  2. How many employees does Vitro Biopharma have?

    Vitro Biopharma has 4 employees
  3. What sector does Vitro Biopharma operate in?

    Vitro Biopharma is in Pharmaceuticals, Biotechnology
  4. Who are Vitro Biopharma's competitors?

    Vitro Biopharma's top competitors are Vericel, Athersys